Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | DDB1 | Q16531 | 2/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 2/20 | 0.33 |
| ▸ | STAT3 | P40763 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21670889 | 0.85 | NPC1 (0.46) | ALDH1A1NPC1RAB9A | |
| SCHEMBL21670886 | 0.81 | GAA (0.32) | TSHR | |
| SCHEMBL21670868 | 0.79 | ALDH1A1 (0.33) | ALDH1A1ALOX15TSHRNPC1RAB9A | |
| SCHEMBL21670879 | 0.79 | GRM5 (0.34) | GRM5DDB1CRBNSTAT3ALDH1A1 | |
| SCHEMBL11988757 | 0.73 | KMT2A (0.42) | ALDH1A1ALOX15TSHRRAB9A | |
| SCHEMBL21670371 | 0.72 | KMT2A (0.32) | ALOX15TSHR | |
| SCHEMBL16386822 | 0.72 | DDB1 (0.42) | GRM5DDB1CRBNSTAT3ALDH1A1 | |
| SCHEMBL6906495 | 0.71 | GABRA1 (0.38) | TSHR | |
| SCHEMBL3687037 | 0.71 | GABRA1 (0.38) | TSHR | |
| SCHEMBL13284156 | 0.70 | ALDH1A1 (0.38) | ALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708429-B2 | Bidentate azolylamido metal-ligand complexes and olefin polymerization catalysts | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-07-25 | — | — | US | disclosed |
| US-11708429-B2 | Bidentate azolylamido metal-ligand complexes and olefin polymerization catalysts | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-07-25 | — | — | US | disclosed |
| US-20210332165-A1 | BIDENTATE AZOLYLAMIDO METAL-LIGAND COMPLEXES AND OLEFIN POLYMERIZATION CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-10-28 | — | — | US | disclosed |
| WO-2020028240-A1 | BIDENTATE AZOLYLAMIDO METAL-LIGAND COMPLEXES AND OLEFIN POLYMERIZATION CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708429-B2 | Bidentate azolylamido metal-ligand complexes and olefin polymerization catalysts | LIG4, PARG, PIN1 | GRM5 2810/4885DDB1 695/4885CRBN 474/4885 |
| US-20210332165-A1 | BIDENTATE AZOLYLAMIDO METAL-LIGAND COMPLEXES AND OLEFIN POLYMERIZATION CATALYSTS | LIG4, PARG, PIN1 | GRM5 2810/4885DDB1 695/4885CRBN 474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.